MicroRNA Expression in Coronary Artery Disease

ISSN: 2211-5374 (Online)
ISSN: 2211-5366 (Print)


Volume 3, 3 Issues, 2014


Download PDF Flyer




MicroRNA

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Pan-Chyr Yang
Department of Internal Medicine
College of Medicine
National Taiwan University
1, Sec 1, Ren-Ai Road
Taipei, 10051
Taiwan, ROC


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


MicroRNA Expression in Coronary Artery Disease

Author(s): John F O’Sullivan, Antoinette Neylon, Catherine McGorrian and Gavin J Blake

Affiliation: Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland.

Abstract

The pathogenesis of atherosclerosis involves the interplay of inflammation, altered cellular activity, angiogenesis, and neointima formation. The main cellular participants in atherosclerosis include vascular endothelial cells, smooth muscle cells, and monocytes. The recent discovery of small, non-coding RNAs, microRNAs (miRNAs), and their influence on these processes has provided a greater molecular insight into atherosclerosis. This in turn has led to increase focus on the potential utility of miRNA subtypes as biomarkers for coronary artery disease. Furthermore miRNAs could potentially provide therapeutic targets for the treatment of atherosclerosis and its complications. In this review, we discuss the experimental and clinical evidence for the role of miRNAs in the pathogenesis of coronary artery disease, the limitations of the data and challenges facing the field.

Keywords: Atherosclerosis, coronary artery disease, microRNA, myocardial Infarction, novel risk factors, plaque rupture.

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 2
Issue Number: 3
First Page: 205
Last Page: 211
Page Count: 7
DOI: 10.2174/22115366113026660018
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science